Back to funds

Avoro Capital Advisors LLC

Updated 6 days ago

Managed by Avoro Capital Advisors Llc • Latest filing Q3 2026

Portfolio value
$9.7B
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$10.2B
Q1 2026$10.2B
Q2 2026$11.1B
Q3 2026$9.7B

Top holdings

30 positions as of Q3 2026

View filing
U

UNITED THERAPEUTICS CORP

Value
$1.5B
Shares
2.76M
% Port
15.41%
A

ASCENDIS PHARMA A/S

Value
$1.2B
Shares
5.05M
% Port
11.87%
K

KRYSTAL BIOTECH INC

Value
$960.7M
Shares
2.89M
% Port
9.91%
A

ARGENX SE

Value
$958.9M
Shares
1.00M
% Port
9.89%
M

MADRIGAL PHARMACEUTICALS INC

Value
$923.9M
Shares
1.83M
% Port
9.53%
K

KYMERA THERAPEUTICS INC

Value
$835.6M
Shares
7.47M
% Port
8.62%
A

ARROWHEAD PHARMACEUTICALS INC

Value
$720M
Shares
11.00M
% Port
7.43%
R

REVOLUTION MEDICINES INC

Value
$440.3M
Shares
2.15M
% Port
4.54%
C

CYTOKINETICS INC

Value
$323M
Shares
4.90M
% Port
3.33%
D

DEFINIUM THERAPEUTICS INC

Value
$268.3M
Shares
7.05M
% Port
2.77%
G

STRUCTURE THERAPEUTICS INC

Value
$205M
Shares
6.56M
% Port
2.12%
X

XENON PHARMACEUTICALS INC

Value
$204.5M
Shares
5.50M
% Port
2.11%
V

VERA THERAPEUTICS INC

Value
$182M
Shares
5.63M
% Port
1.88%
Q

UNIQURE NV

Value
$162.5M
Shares
6.73M
% Port
1.68%
C

CELCUITY INC

Value
$119.3M
Shares
1.50M
% Port
1.23%
T

TAYSHA GENE THERAPIES INC

Value
$116.3M
Shares
23.89M
% Port
1.20%
O

OCULAR THERAPEUTIX INC

Value
$95M
Shares
12.38M
% Port
0.98%
?
18.N/A

DAMORA THERAPEUTICS INC

Value
$80.5M
Shares
3.78M
% Port
0.83%
C

HEMAB THERAPEUTICS HLDGS INC

Value
$58.4M
Shares
1.89M
% Port
0.60%
V

VIRIDIAN THERAPEUTICS INC

Value
$51.5M
Shares
2.50M
% Port
0.53%

Explore